Filtered By:
Cancer: Lung Cancer

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 15396 results found since Jan 2013.

JAMA Internal Medicine —The Year in Review, 2020
We welcome the promise of 2021 —to start to get control of the global pandemic via vaccinations against SARS-CoV-2 and effective public health measures and hopefully let the country get back to the hard work of promoting high-value health care that is affordable and available to all Americans. As a new US administration with si gnificant health care expertise begins work, we are hopeful to see progress on complex issues, such as value-based payment, drug pricing, and transparency issues, to name a few.We are interested to learn what the impact of sharply reduced elective health care visits and reduced cancer screenings w...
Source: JAMA Internal Medicine - March 22, 2021 Category: Internal Medicine Source Type: research

Precise medicine of programmed cell death-1/programmed cell death 1 ligand 1 inhibitor immunotherapy combined radiotherapy for inoperable advanced lung cancer: A protocol for systematic review and meta-analysis
Conclusions: The findings of the systematic review will provide scientific evidence of the efficacy and safety of PD1/PD-L1 inhibitor combined radiotherapy for inoperable advanced lung cancer to guide the clinician's drug use. Ethics and dissemination: Not applicable. INPLASY registration number: INPLASY202140123.
Source: Medicine - June 18, 2021 Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research

TECHNIQUE Application of Radiomics and Artificial Intelligence for Lung Cancer Precision Medicine
Medical imaging is the standard-of-care for early detection, diagnosis, treatment planning, monitoring, and image-guided interventions of lung cancer patients. Most medical images are stored digitally in a standardized Digital Imaging and Communications in Medicine format that can be readily accessed and used for qualitative and quantitative analysis. Over the several last decades, medical images have been shown to contain complementary and interchangeable data orthogonal to other sources such as pathology, hematology, genomics, and/or proteomics. As such, "radiomics" has emerged as a field of research that involves the pr...
Source: Cold Spring Harbor perspectives in medicine - August 2, 2021 Category: Research Authors: Tunali, I., Gillies, R. J., Schabath, M. B. Tags: Lung Cancer: Disease Biology and Its Potential for Clinical Translation TECHNIQUE Source Type: research

The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching
CONCLUSION: Long-term CHM treatment with the Fuzheng Quxie Formula, which can be flexibly applied in the course of lung cancer treatment, not only has a positive influence on the progression-free survival time of lung cancer patients, but also reduces the risk of recurrence and metastasis of lung cancer.PMID:34475962 | PMC:PMC8407994 | DOI:10.1155/2021/5522934
Source: Evidence-based Complementary and Alternative Medicine - September 3, 2021 Category: Complementary Medicine Authors: Li-Li Xu Su-Fang Zhang Yu-Li Wang Ying-Bin Luo Zhi-Hong Fang Yuan Fang Rong-Zhong Xu Peng Guo Jian-Chun Wu Yan Li Source Type: research

Traditional herbal medicine combined with first-line platinum-based chemotherapy for advanced non-small-cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
Background: Non-small-cell lung cancer (NSCLC) is a major health burden in many countries. This review aimed to evaluate the efficacy of traditional herbal medicine (THM) combined with first-line platinum-based chemotherapy (PBCT) for the treatment of advanced NSCLC. Methods: From inception to April 2021, relevant studies were retrieved from 9 electronic databases. Randomized controlled trials (RCTs) comparing survival outcomes of THM + PBCT treatment with PBCT treatment in patients with advanced NSCLC were reviewed. The risk of bias was evaluated using the Cochrane Risk of Bias Tool. Overall survival, 1-yea...
Source: Medicine - September 17, 2021 Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research

Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models
Evid Based Complement Alternat Med. 2022 Sep 21;2022:6404853. doi: 10.1155/2022/6404853. eCollection 2022.ABSTRACTNon-small-cell lung cancer (NSCLC) is known as one of the most lethal cancers, causing more than 1 million deaths annually worldwide. Therefore, the development of novel therapeutic drugs for NSCLC has become an urgent need. Herein, various mouse models provide great convenience not only for researchers but also for the development of antitumor drug. Meanwhile, TCM, as a valuable and largely untapped resource pool for modern medicine, provides research resources for the treatment of various diseases. Until now,...
Source: Evidence-based Complementary and Alternative Medicine - October 3, 2022 Category: Complementary Medicine Authors: Hongkui Chen Min Zheng Wenhui Zhang Yuan Long Yu Xu Man Yuan Source Type: research

Costs of traditional Chinese medicine treatment for inpatients with lung cancer in China: a national study
Traditional Chinese Medicine (TCM) has long been a widely recognized medical approach and has been covered by China ’s basic medical insurance schemes to treat lung cancer. But there was a lack of nationwide re...
Source: BMC Complementary and Alternative Medicine - January 9, 2023 Category: Complementary Medicine Authors: Hanlin Nie, Zhaoran Han, Stephen Nicholas, Elizabeth Maitland, Zhengwei Huang, Sisi Chen, Zegui Tuo, Yong Ma and Xuefeng Shi Tags: Research Source Type: research

Precision Medicine May Have a New Lung Cancer Treatment That Can Be Staged with an EGFR Test as a Companion Diagnostic
There’s evidence that a cancer drug can cut deaths from lung cancer by as much as 50% when pathology testing indicates the patient has the EGFR mutation Results from a decade-long clinical trial indicate that lung cancer patients with the epidermal growth factor receptor (EGFR) mutation have significantly better survival rates when treated with the […] The post Precision Medicine May Have a New Lung Cancer Treatment That Can Be Staged with an EGFR Test as a Companion Diagnostic appeared first on Dark Daily.
Source: Dark Daily - July 17, 2023 Category: Laboratory Medicine Authors: swallask Tags: Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine Source Type: news

Are high-speed cyclists at risk from air pollution?
Conclusion This study may be of interest to those in the field of sports medicine. It calculates the speed that walkers, joggers and cyclists may travel at to minimise the pollution they potentially inhale. It also finds that these values turn out to be those that many pedestrians and cyclists would travel at in any case. And, somewhat unsurprisingly, this speed would go down as you go uphill because of the increased effort and breathing rate required. Fitter people who run or cycle fast for sport are, however, naturally likely to exceed this minimum speed requirement, both on the flat and speed gradients. This could pot...
Source: NHS News Feed - October 31, 2016 Category: Consumer Health News Tags: Heart/lungs Lifestyle/exercise Source Type: news

Smokers Die About A Decade Earlier On Average
WebMD Medical News By Salynn Boyles Reviewed by Laura J. Martin, MD Jan. 23, 2013 — Women who smoke are now just as likely to die of lung cancer and other smoking-related diseases as men — and smokers of both sexes die, on average, about a decade earlier than non-smokers. These were among the findings from two major studies examining death rate trends among smokers published in The New England Journal of Medicine. “The studies highlight the fact that cigarette smoking remains a leading cause of death in the U.S.,” says Steven A. Schroeder, MD, who directs the Smoking Cessation Leadership Center at ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 30, 2013 Category: Consumer Health News Authors: mreal197 Tags: WebMD News Source Type: news

12 Amazing Things We Learned About The Human Body In 2015
The human body is a source of mystery. But every year, scientists get just a little better at understanding its secrets.  Of course, 2015 has been no different. In the past year, researchers have created better access to proven therapies, developed futuristic new technologies that may change the way we approach disease and even enacted more complete disease screening processes to keep us healthy.  Read on to learn more. Here’s to more scientific discoveries in 2016!   @media (max-width: 969px) { #desktop { display: none; } } @media (min-width: 970px) { #mobile { display: none; } } #g-body-de...
Source: Science - The Huffington Post - December 22, 2015 Category: Science Source Type: news

FDA clears GE CT scanners for lung cancer screening
Several GE Healthcare CT scanners have been cleared by the U.S. Food and Drug...Read more on AuntMinnie.comRelated Reading:GE sells off healthcare financing unit, August 11, 2015GE to invest $1B for clinical education, July 29, 2015GE to provide imaging at 2015 CrossFit Games, July 20, 2015GE offers new 4D cardiac ultrasound software, July 14, 2015GE, NBA to promote sports medicine research, July 9, 2015
Source: AuntMinnie.com Headlines - August 17, 2015 Category: Radiology Source Type: news

Yoga May Give Lung Cancer Patients, Caregivers a Boost
Source: The Doctors Lounge - Oncology - November 7, 2017 Category: Cancer & Oncology Tags: Nursing, Oncology, Sports Medicine, News, Source Type: news

Exercise May Help Lung Cancer Surgery Go More Smoothly
Source: The Doctors Lounge - Oncology - February 2, 2018 Category: Cancer & Oncology Tags: Oncology, Pulmonology, Surgery, Sports Medicine, News, Source Type: news